9430 KEY WEST AVENUE, ROCKVILLE, MD
Shareholder votes
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Investor Webinar September 2, 2026
Annual Meeting Results - 20/20 Biolabs, Inc. Votes on Five Proposals
Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level
Investor Webinar August 5, 2026
20/20 Biolabs Enters $40 Million Securities Purchase Agreement
Investor Webinar July 1, 2026
Q1
Notice of Late Filing for Quarterly Report
FY 2025
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Schedule 13D - Ownership Report
Schedule 13G - Ownership Report
Post-Effective Amendment to Registration Statement
Amended Annual Report for Regulation A
Current Report for Regulation A
Amended Certified Report
Certified Report